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Purpose: Four pediatric patients with congenital coronary 
arteriovenous fistula (CAVF) were reported to remind pediatric 
practitioners and cardiologists of its diagnosis and manage-
ment.  Materials and Methods: Four pediatric patients with 
congenital CAVF from June 1999 to November 2007 were 
included in this retrospective study. Study modalities included 
reviews of patients’ profiles of clinical features, chest radio-
graph, Doppler echocardiography, cardiac catheterization with 
angiography, myocardial perfusion scan, and computed tomo-
graphy. Results: All 4 patients were symptomatic. The clinical 
symptoms and signs were feeding problem, continuous murmur, 
tachycardia, tachypnea, cardiomegaly, and exertional chest 
pain. Myocardial enzyme was elevated in 1 patient. Echo-
cardiography showed dilatation of the coronary artery in all 
4 patients, and traced down its origin in 3 and drainage in 4. 
The fistulas originated from the right coronary artery in 2 
patients and left coronary artery in 2, and were drained into 
the right ventricle in 2, right atrium in 1, and pulmonary artery 
in 1. Single left coronary artery was found in 1 patient. The 
pulmonary-to-systemic blood flow ratios ranged from 1.2 to 
2.5. Transcatheter coil occlusion was successfully performed 
in 4 patients through a coaxial delivery system. The symptoms 
and signs of congestive heart failure and myocardial ischemia 
disappeared after the procedure. Conclusion: Diagnosis of con-
genital CAVF could be achieved by appreciation of continuous 
murmur over area unusual for the ductus, and by scrupulous 
examination of echocardiography as well as angiography of 
the coronary artery through which coaxial transcatheter coil 
occlusion could be performed successfully.
Key Words: Coronary arteriovenous fistula, transcatheter coil 
occlusion, coaxial delivery system, doppler, echocardiography, 
cardiac catheterization, angiography, myocardial ischemia
INTRODUCTION
Congenital coronary arteriovenous fistula (CAVF) 
is a rare anomaly through which coronary blood 
flow is usually shunted into a cardiac chamber, 
great vessel, or other structures, bypassing the 
myocardial capillary network to render coronary 
steal phenomenon and myocardial ischemia, and 
causing morbidity and mortality.
1-5 Surgical inter-
vention had previously been advocated to treat 
congenital CAVF.
6-9 Up to date, transcatheter coil 
occlusion emerges as the treatment of choice.
10-18 
In this article, 4 pediatric patients with congenital 
CAVF presenting congestive heart failure and 
myocardial ischemia are reported. In addition, the 
diagnosis, differential diagnosis, and management 
of congenital CAVF are discussed, and its outcome 
following transcatheter coil occlusion by means of 
a coaxial delivery system is reviewed from the 
English literature.
MATERIALS AND METHODS
From June 1999 to November 2007, 4 pediatric 
patients with congenital CAVF (3 male and 1 
female) aged 49 days to 10 years, were treated and 
included in this retrospective study. Patients with 
anomalous left coronary artery from pulmonary Meng-Luen Lee
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Fig. 1. (A) Cross section of the coaxial delivery system, which is composed of a strong "supportive catheter" of either 5- 
French Amplatz Right I Catheter or 5-French Judkins Coronary Catheter in the outer layer (denoted as Arabic numeral 1),
a flexible "target-tracker catheter" of either 2.4-French Progreat or 2.5-French Tracker-18MX Infusion Catheter in the inner 
layer (denoted as Arabic numeral 2), and (B and C) cone-shaped Vortx-18 or (D) S-shaped Complex Helical Fibered Platinum
Coil-18 followed by the Coil Pusher-16 in the central core (denoted as Arabic numeral 3). By means of this coaxial delivery
system, two different modalities of Fibered Platinum Coil-18, which were chosen according to the geometry of fistula, could
be steadily dislodged at the distal end by the Coil Pusher-16 through the flexible infusion catheter of "Progreat" or "Tracker-
18MX" within the meandering congenital CAVF. CAVF, coronary arteriovenous fistula.
AB
CD
artery syndrome were excluded. The study moda-
lities included reviews of patients' profiles of 
clinical manifestations, plain chest radiographs, 
echocardiography with Doppler, cardiac catheteri-
zation with angiography, myocardial perfusion 
scan, and computed tomography. Informed consent 
was obtained from all parents. Transcatheter coil 
occlusion was performed by means of a coaxial 
delivery system composed of: 1) a 5.2-French 
Judkins Coronary Catheter (Johnson-Johnson, 
Miami, FL, USA) or a 5-French Amplatz Right I 
(Medtronic, Minneapolis, MN, USA) in the outer 
layer, 2) 2.5-French Target Tracker-18MX Infusion 
Catheter (Target, Fremont, CA, USA) or 2.4-French 
Progreat (Terumo, Fujinomiya, Shizuoka, Japan) in 
the inner layer, and 3) Fibered Platinum Coil 
followed by Vortx Coil Pusher-16 (Target, Medi- 
tech, Watertown, MA, USA) in the central core 
(Fig. 1). The Amplatz Right I or the Judkins 
Coronary Catheter may serve as a strong suppor-
tive catheter in the outer layer, and the Infusion 
Catheter of Progreat or the Target Tracker-18MX 
serve as a flexible "target-tracker catheter" in the 
inner layer. By this steady coaxial delivery system, 
the fibered platinum coil could easily be pushed 
out of the infusion catheter by a pusher wire 
(Vortx Coil Pusher-16). Two modalities of 0.018-in 
fibered platinum coils were chosen to occlude the 
fistulas, including the cone-shaped Vortx-18 and 
the S-shaped Complex Helical Fibered Platinum 
Coil-18. Prior to coil occlusion, a coronary balloon 
catheter of 4.0 mm in diameter and 2.0 cm in 
length (HAYATE, Terumo, Tokyo, Japan) was 
inflated for 5 minutes to confirm the absence of 
myocardial ischemia on electrocardiogram in the 
catheterization room. Intravenous heparin was Congenital Coronary Arteriovenous Fistula 97
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Table 1. Clinical Profiles of 4 Pediatric Patients with Congenital CAVF Underwent Transcatheter Coil Occlusion through 
a Coaxial Delivery System
No. Age/Sex Chief complaints CHF/MI Origin Drainage Qp/Qs Coil no., modality Outcome
1 49 days/
M
Heart murmur,
Prolonged feeding 
Yes/No RCA
5.0 mm
RV
3.3 mm
2.5 1, 0.018-in FPC Survived
 
2 15 months/
F
Heart murmur,
Postprandial dyspnea
Yes/Yes LAD
4.0 mm
RV
2.0 mm
1.3 3, 0.018-in FPC Survived
3 22 months/
M
Heart murmur, 
Postprandial dyspnea
Yes/No LAD
6.0 mm
RA
3.5 mm
1.5 4, 0.018-in FPC Survived
4 10 years/
M
Exertional chest pain, 
Pallor; Cold sweating
No/Yes RCA
4.5 mm
PA
1.8 mm
1.2 3, 0.018-in FPC Survived
CAVF, coronary arteriovenous fistula; CHF, clinical symptoms and signs of congestive heart failure, including tachycardia, tachypnea 
(or dyspnea), and cardiomegaly; F, female; FPC, fibered platinum coil; LAD, left anterior descending coronary artery; M, male; MI, 
myocardial ischemia; PA, pulmonary artery; Qp/Qs, pulmonary-to-systemic flow ratio; RA, right atrium; RCA, right coronary artery; 
RV, right ventricle.
given to prevent blood clotting in this coaxial 
system of delivery beforehand. Aortography and/ 
or selective angiography of the incriminated 
coronary artery were performed 20 minutes after 
the procedure to document the final results.
RESULTS
The clinical profiles of 4 pediatric patients with 
CAVF are summarized in Table 1. All 4 patients 
were symptomatic, and their ages ranged from 49 
days to 10 years. The most common symptoms 
and signs calling for medical help were feeding 
problems (n = 3), continuous murmur (n = 3), tachy-
cardia (n = 3), tachypnea (n = 3), cardiomegaly (n 
= 3), and exertional chest pain with cold sweating 
(n = 1). Myocardial enzyme was elevated in 1 
patient (patient 2). Echocardiography showed 
dilatation of the coronary artery in 4 patients. The 
origin and drainage of CAVF could be identified 
in 3 and 4 patients, respectively. Single left CAVF 
was documented in patient 2, who presented 
symptoms and signs of congestive heart failure 
and myocardial ischemia. Patient 4 was a 10-year- 
old boy who had suffered from Kawasaki disease 
at 3 years of age, and was free of symptoms and 
signs during 7 years of follow up. However, he 
presented chest pain, cold sweating, and pale face 
after 100-m dashing and long-distance jogging in 
the past 3 months. Myocardial perfusion scan or 
stress/rest 
99mtechnetium-methoxyisobutylisonitrile 
(
99mTc-MIBI) single-photon emission computed 
tomography with a bicycle ergometer, which was 
performed in order to assess coronary artery 
stenosis, showed reversible perfusion abnormality 
in the basal inferoseptal segment, basal inferior 
segment, mid-inferior segment, and apical inferior 
segment, indicating myocardial ischemia involving 
the territory of the right coronary artery. 
According to angiographic imaging, the fistulas 
originated from the right coronary artery in 2 
patients (patients 1 and 4) and left coronary artery 
in 2 (patients 2 and 3), and drained into the right 
ventricle in 2 (patients 1 and 2), right atrium in 
1 (patient 3), and the pulmonary artery in 1 
(patient 4). The pulmonary-to-systemic blood flow 
(Qp/Qs) ratios ranged from 1.2 to 2.5. Transca-
theter coil occlusion was successfully performed 
through the coaxial delivery system in all 4 
patients. The symptoms and signs of congestive 
heart failure, continuous murmur, and exertional 
chest pain disappeared after the procedure in all 
patients. Myocardial perfusion scan showed 
regression of reversible perfusion abnormality in 
patient 4 at 1-year follow up.
Illustrated case
Patient 2 was a 15-month-old female who was Meng-Luen Lee
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Fig. 2. (A and B) Selective angiography of the left coronary artery, which was entered by a 5-French Amplatz Right I (AR 
I), showed a single left coronary arteriovenous fistula (CAVF) originating from left anterior descending coronary artery 
(LAD) draining to the right ventricle. (C and D) With the aid of a rail offered by a 0.014-in PTCA Guide Wire, a 2.4-French 
Progreat Infusion Catheter (PIC), which was passed through a 5-French Amplatz Right I (AR I) that approached the left 
coronary artery at the orifice, tracked this meandering single left CAVF to the distal end. Transcatheter coaxial coil occlusion 
was performed, after removal of the 0.014-in guide wire, using a Vortx Coil Pusher-16 to dislodge 3 sets of 0.018-in Fibered 
Platinum Coil (FPC). (E and F) Selective angiography of the left coronary artery, 15 minutes. after coil occlusion, showed 
complete occlusion of the fistula and visualization of the left circumflex coronary a r t e r y  ( L C X ) ,  i m p l y i n g  p r e s e n c e  o f  
insidious coronary artery steal phenomenon caused by this fistulous shunting.
A B
C D
E F
referred from a pediatric clinic with the chief 
complaints of heart murmur, postprandial tachy-
cardia, and postprandial dyspnea at the age of 11 
months. Vital signs showed increased heart rate of 
140 bpm, increased respiratory rate of 32 bpm, 
and normal blood pressure of 108/68 mmHg. 
Under sedation by choral hydrate, a faint con-
tinuous murmur of grade 2/6 could be appreciated 
over the right sternal border on chest auscultation. 
The liver was impalpable. Plain chest radiograph 
showed cardiothoracic ratio of 55%. There were 
no pathological Q waves in leads I, aVL, and V5- Congenital Coronary Arteriovenous Fistula 99
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6 on electrocardiogram. Initially, myocardial en-
zymes were within normal limits. Doppler echo-
cardiography and cardiac catheterization with 
angiography tracked down the culprit to be a 
single left CAVF to the right ventricle. Her parents 
were hesitant to accept interventional cardiac 
catheterization at first. Oral nitroglycerin, aspirin, 
and digitalis were prescribed for the patient at the 
outpatient clinic of the Division of Pediatric 
Cardiology. Unfortunately, she suffered from 
acute bronchiolitis with remarkable tachypnea 
and tachycardia 4 months later. Thrombocytosis 
was noted with platelet counts of 1,030,000/mm
3. 
Serum level of the myocardial fraction of creatine 
kinase (CK-MB) was 15.0 ng/mL (> 6.3 ng/mL) 
and that of creatine kinase was 186 U/L (> 113 
U/L). After speaking to her parents about the 
high probability of sudden cardiac death pro-
voked by acute coronary occlusion secondary to 
thrombocytosis or elicited by coronary artery steal 
phenomenon following any other physical stress 
or illness and the high success rate and low compli-
cation of transcatheter coil occlusion by a coaxial 
delivery system, they parents finally agreed to 
interventional cardiac catheterization. We did not 
prescribe antibiotics for prophylaxis prior to cardiac 
catheterization. Heparin was administrated intra-
venously in a dosage of 100 U/kg. At cardiac 
catheterization, pulmonary artery pressure was 
24/14 mmHg (mean, 17), right ventricular pres-
sure 24/5 mmHg, and aortic pressure 88/55 mmHg 
(mean, 74). Qp/Qs ratio was 1.3. Ascending aorto-
graphy and selective angiography of the left 
coronary artery (Figs. 2A and B) showed a single 
left CAVF draining meanderingly to the right 
ventricle. The maximum diameter of the single 
left CAVF was 4 mm at the orifice and 2 mm at 
the termination of the right ventricle. Intravenous 
heparin was given beforehand to prevent blood 
clotting within this coaxial system. A 0.014-in 
PTCA Guide Wire (PT2, Boston Scientific, Miami, 
FL, USA) was applied to track the single left coro-
nary artery, which was approached at the orifice 
by a 5-French Amplatz Right I. With the aid of a 
rail offered by the PTCA Guide Wire, a 2.4-French 
Infusion Catheter of the "Progreat", which was 
passed through a 5-French Amplatz Right I, easily 
t r a c k e d  t h i s  m e a n d e r i n g  s i n g l e  l e f t  C A V F  t o  t h e  
distal end (Figs. 2C and D). Transcatheter coaxial 
coil occlusion was performed after removal of the 
guide wire using a Vortx Coil Pusher-16 to 
dislodge 3 sets of 0.018- in fibered platinum coil, 
2 of which are of cone-shaped (Vortx) and other 
S-shaped (Complex Helical) configuration in the 
looped status after dislodgement. Selective 
angiography of the left coronary artery 15 minutes 
after coil occlusion showed complete occlusion of 
single left CAVF and visualization of the left 
circumflex coronary artery, implying the presence 
of insidious coronary artery steal phenomenon 
caused by this fistulous shunting before (Figs. 2E 
and F). Continuous murmur disappeared. Doppler 
echocardiography showed complete occlusion of 
the fistula. At 3-month follow up, plain chest 
radiograph, 12-lead surface electrocardiogram and 
cardiac enzymes were within normal limits. She 
was free of symptoms and signs of congestive 
heart failure and myocardial ischemia at 12-month 
follow up at the outpatient clinic of the Division 
of Pediatric Cardiology.
It cannot be overemphasized that transcatheter 
occlusion should be performed with caution, even 
in case of congenital single left CAVF presenting 
myocardial ischemia. To the best of our knowledge, 
this is the first case documenting single left CAVF 
that was successfully treated by transcatheter coil 
occlusion through a coaxial delivery system. 
DISCUSSION
Congenital CAVF to a cardiac chamber or a 
great vessel, which is assumed to appear due to 
persistence of embryonic intertrabecular spaces 
and coronary sinusoids, is the most commonly 
encountered congenital anomaly of the coronary 
artery that is liable to cause sudden cardiac 
death.
19-21 The natural history and clinical course 
of congenital CAVF vary significantly among 
patients affected.
4,21,22 It tends to manifest in infants 
< 2 years of age with congestive heart failure; in 
young adults with angina, dyspnea on exertion, 
myocardial ischemia, and myocardial infarction; 
and in adults > 40 years of age with congestive 
heart failure, atherosclerosis, and arrhythmias.
4
The incidence of congenital CAVF was estimated 
to be 0.3 - 0.8%.
2,23 Congenital CAVF may originate 
from any of the 3 major coronary arteries, with the Meng-Luen Lee
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right and left anterior descending coronary arteries 
most commonly involved and the left circumflex 
coronary artery rarely encountered. 
5,10-18,24-26 The 
right coronary artery is incriminated in 55% of 
cases, left coronary artery in 35%, and both coro-
nary arteries in 5%.
5 More than 90% of congenital 
CAVF drains into the venous circulation (right 
ventricle, 41%; right atrium, 26%; and pulmonary 
artery, 17%),
19 with extremely rare exceptions into 
the left ventricle
19,27 and pericardium.
28
Since congenital CAVF drains most commonly 
to the right cardiac chambers (right ventricle and 
right atrium), the single most important clue of 
the fistula is the location of continuous murmur, 
which is atypical for the patent ductus arteriosus. 
Differential diagnosis should include right-side 
patent ductus arteriosus,
29 congenital systemic 
fistula to the pulmonary vein,
30 pulmonary arte-
riovenous malformation,
5 ruptured sinus of 
Valsalva,
31 aortopulmonary window,
32 congenital 
or acquired pulmonary vein stenosis,
33 and aortic 
regurgitation and prolapse of the right coronary 
cusp associated with supracristal ventricular septal 
defect.
34 Congenital CAVF can be diagnosed by 
transthoracic
35,36 and transesophageal echocardio-
graphy
23,37,38 with color Doppler flow mapping, 
and can be defined by laid-back aortography
39 of 
its anatomical features that help facilitate transca-
theter coil occlusion.
10-18 Some new imaging 
modalities, including ultrafast computed tomo-
graphy and magnetic resonance imaging,
40-43 may 
be used as adjunct to coronary angiography to 
measure abnormal tortuous vessels in 1 section. In 
pediatric patients with congenital CAVF, however, 
transthoracic echocardiography and coronary 
angiography would be sufficient in most circums-
tances.
Up to date, there has been 1) no consensus in 
the management strategy for congenital CAVF, 2) 
no incriminated risk factors in asymptomatic 
patients with small fistulas, and 3) no cut off 
value of Qp/Qs bulletining for intervention. Thus, 
the management remains controversial, and 
recommendations are based on anecdotal cases or 
small retrospective series.
10-18,44 At one end of the 
spectrum, the spontaneous closure rate was only 
1% in 18 pediatric patients with congenital fistulas, 
and 16 (asymptomatic in 14 and congestive heart 
failure in 2) of them were operated.
45 At the other 
end, the closure rate was up to 23% in 31 pediatric 
patients with clinically silent fistulas to whom 
conservative management with continued follow- 
up was recommended.
22 Treatment of asympto-
matic adult patients is still under debate since 
most remain free of symptoms for a long time.
46,47 
However, pediatric patients tend to be symptoma-
tic by virtue of larger fistulas that prompt medical 
attention and treatment. Generally speaking, 
patients with larger fistulas or symptoms of con-
gestive heart failure and myocardial ischemia and 
pediatric patients with high Qp/Qs liable to have 
symptoms secondary to coronary steal pheno-
menon should be treated as soon as possible. 
Somehow, clinical symptoms do not significantly 
correlate with Qp/Qs.
4 Furthermore, some patients 
with congenital coronary fistulas present symp-
toms only after provocative test or physical stress 
or illness, similar to patients 2 and 4 in this report. 
Sato reported 1 case with a low Qp/Qs of 1.08 
presenting symptoms of myocardial ischemia only 
after the stress/rest 
99mTc-MIBI SPECT and 
123I- 
BMIPP scintigraphy, indicating surgical interven-
tion.
48 Likewise, patient 4 with a low Qp/Qs ratio 
of 1.2 in this report developed myocardial ischemia, 
probably by means of coronary steal phenomenon 
that reflected on the stress/rest 
99mTc-MIBI SPECT 
with the findings of reversible perfusion abnor-
mality.
Although surgical outcomes of congenital CAVF 
are good,
6-9 catheter-based managements using 
different devices, including detachable balloon,
49 
interlocking detachable coils,
50 Gianturco coils,
10, 
14-18,27 fibered platinum microcoils,
10-13,16,24,25 Am-
platzer Duct Occluder,
51 Amplatzer Vascular Plug,
52 
and a combination of multiple devices (Amplatzer 
muscular VSD Occluder, Amplatzer Duct Occluder, 
flipper coils, and Gianturco-Grifka vascular occlu-
sion device),
53 have been proven to be acceptable 
alternatives to surgery because of their friendly 
manipulation, easy feasibility, excellent results of 
high closure rate, and low morbidity and mortality 
rates.
Before performance of transcatheter coil occlu-
sion, careful assessment of the size and geometry 
of coronary fistulas are crucial for selection of 
coils or other devices to achieve complete occlu-
sion In the present study, we dislodged the 
fibered platinum microcoils at the distal site of Congenital Coronary Arteriovenous Fistula 101
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fistulas, which usually have the smallest diame-
ters. From the clinical experience of our patients 
and those reported in the English literature, the 
terminal insertion and zenith or nadir of a sharp 
U-turn or a serpentine S-curve usually possess the 
narrowest diameters, at which points coils or 
other devices can be safely dislodged without 
causing distal migration to the peripheral pulmo-
nary artery. If there is no discernible narrowest 
site throughout the fistula, larger Gianturco coils 
(0.035-in. or 0.038-in.) or other occlusive devices 
should be considered instead.
If we attempt to occlude the fistula at the pro-
ximal portion of a coronary artery, balloon occlu-
sion test or angiography is mandatory to see if 
there is presence of ischemic changes on electro-
cardiogram or presence of side branch of the 
target coronary artery in the catheterization room. 
In order to avoid myocardial dysfunction, is-
chemia, or even infarction, it is recommended not 
to occlude the fistula at the proximal portion 
unless it is geometrically unfeasible for a distal 
coil occlusion. Balloon occlusion test at the distal 
portion of the fistula can technically be difficult to 
obtain the common feature of its meandering, 
serpentine, or tortuous course. Coronary balloon 
catheters, with small profiles of 2.0 - 4.0 mm in 
diameter and 1.5 - 2.0 cm in length can reach more 
distally and be used for balloon occlusion test or 
angiography without causing significant draw-
backs. If it is difficult to track this small coronary 
balloon catheter deep to the distal end of the 
fistula for test or angiography, we recommend a 
transarterial approach through a coaxial delivery 
system using a larger 5-Fr Judkins Coronary 
Catheter or 6-Fr Coronary Infusion Catheter for a 
strong support at the take-off of the fistula to 
facilitate guiding a 3-Fr flexible Tracker-18MX 
Infusion Catheter to advance more distally for 
precise dislodgement of the fibered platinum 
microcoils. There are 2 major advantages of a 
coaxial transarterial approach over traditional 
transarterial approach (without using a coaxial 
system) and antegrade (or transvenous) approach. 
The technique of transarterial approach by a coaxial 
delivery system involves using smaller sheaths 
and infusion catheters (3-Fr Tracker-18MX), which 
can be housed into a larger 5-Fr Judkins Coronary 
Catheter or 6-Fr Coronary Infusion Catheter to 
form a steady coaxial system to deliver platinum 
microcoils more easily and precisely at the distal 
end of the fistula or at insertion of the right 
cardiac chambers. A coaxial delivery system offers 
better stabilization during transcatheter coil occlu-
sion. Clinical application of a detachable coil, 
umbrella, or balloon, instead of fibered platinum 
microcoils, requires a larger delivery system that 
can be difficult to track the larger Judkins Coronary 
Catheter to the distal end of the coronary fistula. 
Under such circumstances, a transarterial approach 
(without using a coaxial system) will inevitably 
dislodge larger occlusive devices at a more pro-
ximal portion, jeopardizing more of the side 
branches at risk of obstruction. An antegrade or 
transvenous approach has 2 irksome tasks to over-
come. First, a snare catheter may be used to pull 
a guide wire passed from the aorta through the 
coronary artery out of the fistula from a venous 
catheter in the right atrium or right ventricle. 
Second, it is demanding to track a delivery system 
deep enough into the coronary fistula en route 
from the right cardiac chambers to the mean-
dering coronary artery for coil occlusion.
25  Only a 
few cases of antegrade or transvenous approach 
from the pulmonary artery rather than from the 
right atrium or right ventricle have been reported.
54 
Likewise, congenital CAVF to the superior vena 
cava, azygos vein, and coronary sinus can be ap-
proached antegradely or transvenously if indicated 
for transcatheter coil occlusion.
The clinical profiles of 15 pediatric patients with 
congenital CAVF who underwent transcatheter 
coil occlusion by fibered platinum coil through a 
coaxial delivery system are summarized in Table 
2.
In conclusion, diagnosis of congenital CAVF 
could be achieved by canny appreciation of con-
tinuous murmur over area that is unusual for the 
patent ductus arteriosus, by scrupulous examina-
tion of echocardiography, and by selective angio-
graphy of the incriminated coronary artery 
through which transcatheter coil occlusion could 
be performed simultaneously and successfully by 
a coaxial delivery system, even in patients pre-
senting congestive heart failure or myocardial 
ischemia. Single left CAVF did not preclude 
transcatheter coil occlusion by way of a coaxial 
delivery system. Meng-Luen Lee
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Table 2. Review of 15 Pediatric Patients with Congenital CAVF Underwent Transcatheter Coil Occlusion through a 
Coaxial Delivery System
No. Age/Gender Origin Drain Qp/Qs Coil no., modality  Occlusion Author
reference
1 6.3 yrs/M LCA RV - 14, 0.018-in FPC Incomplete Kung et al.
10
2 9.8 yrs/F LCA RA - 7, 0.018-25-in FPC Complete Kung et al.
10
3 4.6 yrs/F RCA RV - 3, 0.018-in FPC Complete Kung et al.
10
4 4.3 yrs/F RCA RV - 2, 0.018-in FPC Complete Kung et al.
10
5 7 wks/M LCA RV - 2, 0.025-in FPC Complete Kung et al.
10
6 2 yrs/F RCA RV - 3, 0.018-in FPC Complete Kung et al.
10
7 5.8 yrs/M LCA RV - 4, 0.018-in FPC Complete Kung et al.
10
8 1.3 yrs/F LCX CS 1.8 2, 0.018-in FPC Complete Ogoh et al.
11
9 3 yrs/F RCA RA 1.5 2, 0.018-in FPC Complete Ogoh et al.
11
10 6 yrs/M LAD PA - 1, 0.018-in FPC Complete Beekman et al.
12
11 2 yrs/F LCA RV 1.8 1, 0.015-in FPC Complete De Wolf et al.
13
12 6 yrs/M LCA RV 2.5 1, 0.018-in FPC Complete Reidy et al.
16
13 2 yrs/M LCA RV 1.8 7, 0.018-in FPC Complete Reidy et al.
16
14 6 yrs/M RCA RV 1.4 1, 0.018-in FPC Complete Sreedharan et al.
24
15 16 months/F LAD RV - 2, 0.018-in FPC Complete Vance
25
CAVF, coronary arteriovenous fistula; CS, coronary sinus; F, female; FPC, fibered platinum coil; LCA, left coronary artery; LCX, left 
circumflex artery; M, male; PA, pulmonary artery; Qp/Qs, pulmonary-to-systemic flow ratio; RA, right atrium; RCA, right coronary 
artery; RV, right ventricle.
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